Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…
Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), October 3, 2025,…
ASM hosts Investor Day, provides new 2030 targets, revises H2 2025 outlook
Almere, The Netherlands September 23, 2025, 7:45 a.m. CET ASM International N.V.…
Eutelsat and Multimedios Televisin Consolidate Longstanding Satellite Partnership in Mexico
Multimedios Televisión renews capacity on EUTELSAT 117 West A satellite for media…
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program…
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
Ipsen – July 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
HAFNIA LIMITED: Key Information Relating to Dividend for the Second Quarter 2025
SINGAPORE--(BUSINESS WIRE)--Reference is made to the announcement made by Hafnia Limited ("Hafnia”…
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
August 21, 2025 01:30 ET | Source: NICOX SA Press Release Nicox…
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ in Elderly and Updates to the Prescribing Information
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext…